Investigational malaria pill for adults with uncomplicated malaria
Treatments studied
Part of Infections clinical trials.
This study tests a new malaria pill in adults with uncomplicated malaria (mild form). The pill aims to treat the infection, and participation involves monitoring and follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults aged 18 to 65 years
- Have a confirmed malaria infection with the falciparum species, with fever and a certain level of parasites in the blood
- Body mass index (BMI) between 18 and 30
- Able to swallow oral medication
- Women of childbearing age must use effective contraception during the study
- No signs of severe malaria or other significant medical conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug (GSK4425689A) for the first time in humans. It is a healthy volunteer study to check the safety, side effects, and how the drug moves through the body. It may help in the future development of treatments for malaria.
This study tests a genetically modified malaria parasite that is intentionally given to healthy volunteers through a mosquito bite. The goal is to see if it is safe and to learn how the immune system responds, which could help develop a malaria vaccine.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study tests a new malaria vaccine in healthy adults. You will receive the vaccine and then be exposed to the malaria parasite in a controlled setting to check if the vaccine protects you.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
Hear when a new Malaria Falciparum trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.